ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI ConferenceTwo members of the ClearTrial clinical services team to present the critical processes that comprise a more accurate forecast and budget discipline across clinical development departments Chicago, IL – February 8, 2010 ClearTrial, the leading provider of Clinical Trial Operations (CTO) software, today announced that both Kristin Lucas and Kelly Larrabee, Directors, Clinical Services at ClearTrial, have been selected to speak at the CBI Forecasting & Budgeting conference at the Marriott Courtyard Downtown in Philadelphia on February 8, 2010. Predictive modeling, expert project planning and tracking, outsourcing, re-forecasting, accruals and reporting are some of the critical processes they will address in order to provide a more accurate forecast and budget discipline.
Also at the conference, Kristin Lucas will introduce new Clinical Financial Best Practices guidelines and share industry best practices for managing the clinical financial plan from “plan to payment.” Kristin will discuss how implementing a set of integrated processes across clinical development departments can result in significant operational efficiencies, accelerated operations, improved outsourcing and licensing arrangements and improved financial controls.
About the Speakers About ClearTrial® ClearTrial is the leading provider of Clinical Trial Operations (CTO) software, a seamlessly integrated system for clinical operations planning, forecasting, outsourcing, and project tracking. ClearTrial’s award-winning software helps life sciences companies streamline their clinical operations from Plan to Payment™ without sacrificing quality of results, providing executives and functional leaders in clinical operations, resource planning, finance, outsourcing, and project management with a common platform that promotes speed, accuracy, and consistency throughout the organization. For more information please visit http://www.cleartrial.com. ClearTrial® and the ClearTrial logo are registered trademarks owned by ClearTrial, LLC, which may be registered in certain jurisdictions. Any other company or product names mentioned in this release are hereby acknowledged as registered trademarks or trademarks of their respective owners. For more information contact: Mike Lange |
ClearTrial is a lifesaver in terms of making wise clinical investment decisions. It has made a significant difference in my ability to help our business. Thanks!

